Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Lydia Mills, MSW, LCSW, LICSW

Advertisement

Articles by Lydia Mills, MSW, LCSW, LICSW

Erin Crum, MPH, senior director, quality strategy and innovation, The US Oncology Network

McKesson's Patient-Reported Outcomes Measure Will Track Improvements in Health-Related Social Needs

ByErin Crum, MPH,Lydia Mills, MSW, LCSW, LICSW
October 16th 2024

The use of patient-reported outcome measures—the gold standard in quality measurement—is crucial to building a patient-centered, value-based care system.

Advertisement

Latest Updated Articles

  • Erin Crum, MPH, senior director, quality strategy and innovation, The US Oncology Network
    McKesson's Patient-Reported Outcomes Measure Will Track Improvements in Health-Related Social Needs

    October 16th 2024



Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

2

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC

3

Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC

4

Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments

5

Sonrotoclax Approval Generates New Options and Possibilities for R/R MCL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us